|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Application of numerical modeling and genetic programming to estimate rock mass modulus of deformation显示文摘Estimation of the rock mass modulus of deformation(Em)is one of the most important design parameters in designing many structures in and on rock.This parameter can be obtained by in situ tests,empirical relations between deformation modulus and rock mass classifcation,and estimating from laboratory tests results.In this paper,a back analysis calculation is performed to present an equation for estimation of the rock mass modulus of deformation using genetic programming(GP)and numerical modeling.A database of 40,960 datasets,including vertical stress(rz),horizontal to vertical stresses ratio(k),Poisson’s ratio(m),radius of circular tunnel(r)and wall displacement of circular tunnel on the horizontal diameter(d)for input parameters and modulus of deformation for output,was established.The selected parameters are easy to determine and rock mass modulus of deformation can be obtained from instrumentation data of any size circular galleries.The resulting RMSE of 0.86 and correlation coeffcient of97%of the proposed equation demonstrated the capability of the computer program(CP)generated by GP. | Ebrahim Ghotbi Ravandi Reza Rahmannejad Amir Ehsan Feili Monfared Esmaeil Ghotbi Ravandi | 2013 | International Journal of Mining Science and Technology2013，23，5： | 5 |
| 2 | Phase Ⅱ study of arsenic trioxide in patients with relapsed or refractory multiple myeloma显示文摘 | Hussein M A Saleh M Ravandi F | 2004 | Br J Haematol2004，125，4： | 1 |
| 3 | The influence of solvent type and polymer concentration on the physical properties of solid state polymerized PA 66 nanofiber yarn显示文摘 | SANATGAR Razieh Hashemi BOHANI Sedigheh RAVANDI S A H | | 0，，3： | 1 |
| 4 | Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System显示文摘 | Kantarjian H O'Brien S Ravandi F | | 0，，： | 1 |
| 5 | Cotton yarn engineering via fuzzy least squares regression显示文摘 | FATTAHI S TAHERI S M RAVANDI H | 2012 | Fibers and Polymers2012，13，3： | 1 |
| 6 | Efficacy of tosedostat,a novel,oral agent for elderly patients with relapsed or refractory acute myeloid leukemia:a review of the Phase II OPAL trial显示文摘 | Mathisen MS Ravandi F | | 0，，04： | 1 |
| 7 | Clofarabine plus low- dose Cytarabine followed by Clofarabine plus low-dose Cytarabine alternating with Decitabine in AML frontline therapyof older patients 显示文摘 | Faded A Ravandi F Huang X | 2012 | Cancer2012，118，18： | 1 |
| 8 | Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations显示文摘 | Loghavi S Zuo Z Ravandi F | 2014 | J Hematol Oncol2014，7，1： | 1 |
| 9 | Intensive chemotherapy does not benefit most older patients( age 70 years or older)with acute myeloid leukemia显示文摘 | Kantariian H Ravandi F O'Brien S | 2010 | Blood2010，116，22： | 1 |
| 10 | A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myeiodysplastic syndrome显示文摘 | Faderl S Ravandi F Huang X | 2008 | Blood2008，112，5： | 1 |
| 11 | Effective treatment of acute promy-elocytic leukemia with all-trans retinoic acid,arsenic trioxide,and gemtuzumab ozogamicin显示文摘 | Ravandi F Estey E Jones D | | 0，，： | 1 |
| 12 | Eradication of leukemia stem cells as a new goal of therapy in ceukemia 显示文摘 | Ravandi F Estrov Z | 2006 | Clin Cancer Res2006，12，2： | 1 |
| 13 | Activity of decitabine in the treatment of patients with chronic myelomonocytic leukemia显示文摘 | Aribi A Borthakur G Ravandi F | 2007 | Cancer2007，109，4： | 1 |
| 14 | Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin 显示文摘 | Ravandi F Estey E Jones D | 2009 | J Clin Oncol2009，27，4： | 1 |
| 15 | Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid,Arsenic trioxide,and gemtuzumab ozogamicin显示文摘 | Ravandi F Estey E Jones D | | 0，，04： | 1 |
| 16 | Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance显示文摘 | Ravandi F Kantarjian HM Talpaz M | 2001 | Cancer2001，91，11： | 1 |
| 17 | Cellular signaling pathways: new targets in leukaemia therapy显示文摘 | Ravandi F Talpaz M Kantarjian H | 2002 | Br J Haematol2002，116，1： | 1 |
| 18 | Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mu- tant AML in first relapse显示文摘 | Levis M Ravandi F Wang ES | 2011 | Blood2011，117，12： | 1 |
| 19 | Phase I/II study of combi- nation therapy with sorafenib,idambicin,and cytarabine in youn- ger patients with acute myeloid leukemia显示文摘 | Ravandi F Cortes JE Jones D | 2010 | J Clin Oncol2010，28，11： | 1 |
| 20 | Prognostic fac- tors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabine 显示文摘 | Jabbour E Garcia-Manero G Ravandi F | 2013 | Clin Lymphoma Myeloma Leuk2013，13，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员